In recent years, left ventricular assist devices (LVADs) have been successfully used as a bridge to heart transplantation or as destination therapy (DT) for the treatment of congestive heart failure (CHF). Continuous flow LVADs are smaller, more reliable, and less complex than the first generation LVADs (pulsatile). 1-4 The development of control systems which are able to adapt according to the body's metabolic demands is called physiological control. Research in this field has already been done since the early 1990s. 5-8 The purpose of LVAD control